RE:RE:Also keep in focus the NDA (new drug application) cos' we Yeah, it's frustrating..look at Danny deadlocks 40pg report..the business of medipharm labs has significant, numerous momentous events..regulatory drivers in our international markets continue to push triple digit YOY market growth...eventually all this will translate to the financials...business momentum doesn't always translate to stock price momentum..at some point it will fly.